Boothbay Fund Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,680
Closed -$29.6K 1659
2025
Q1
$29.6K Hold
4,680
﹤0.01% 1312
2024
Q4
$48.3K Buy
4,680
+27
+0.6% +$297 ﹤0.01% 1357
2024
Q3
$59.8K Hold
4,653
﹤0.01% 1499
2024
Q2
$64.4K Hold
4,653
﹤0.01% 1392
2024
Q1
$1.45M Sell
4,653
-346
-7% -$92.2K 0.03% 619
2023
Q4
$1.31M Buy
4,999
+319
+7% +$57.7K 0.03% 639
2023
Q3
$915K Buy
4,680
+1,406
+43% +$252K 0.02% 808
2023
Q2
$673K Buy
3,274
+2,580
+372% +$358K 0.01% 984
2023
Q1
$69.8K Hold
694
﹤0.01% 1997
2022
Q4
$109K Hold
694
﹤0.01% 1760
2022
Q3
$174K Sell
694
-73
-10% -$21.6K ﹤0.01% 1895
2022
Q2
$217K Sell
767
-3
-0.4% -$817 0.01% 1680
2022
Q1
$155K Hold
770
﹤0.01% 1979
2021
Q4
$168K Sell
770
-14
-2% -$4.5K ﹤0.01% 1548
2021
Q3
$358K Sell
784
-879
-53% -$332K 0.01% 1244
2021
Q2
$668K Sell
1,663
-10
-0.6% -$4.56K 0.02% 874
2021
Q1
$970K Sell
1,673
-74
-4% -$46.2K 0.04% 614
2020
Q4
$996K Buy
1,747
+874
+100% +$492K 0.04% 494
2020
Q3
$488K Buy
+873
New +$543K 0.03% 652

Other funds holding LYRA

Boothbay Fund Management's LYRA Position: Q2 2025 in Review

Boothbay Fund Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 4,680 shares — an estimated $29.6K sold.

Boothbay Fund Management first reported a position in LYRA in Q3 2020 and held it in 19 quarters. The position peaked at $1.45M in Q1 2024. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • Boothbay Fund Management reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 4,680 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $29.6K.
  • Boothbay Fund Management first reported a position in LYRA THERAPEUTICS INC in Q3 2020 and held it in 19 quarters.
  • Boothbay Fund Management's LYRA THERAPEUTICS INC position peaked at $1.45M in Q1 2024.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on Boothbay Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.